Table 3. Drug screening program.

Project	Grouping	Protocol
Control	No
1	Olaparib + adavosertib	Ada, 30 mpk, po, qd*7 + Ola, 100 mpk, po, qd*7
2	Trametinib	Traetinib 1 mpk, po, qd*7
3	Crizotinib	Crizotinib 50 mpk, po, qd*7
4	5-FU + CF + Oxa	5-FU 25 mpk, ip, qd*5 + CF 50 mpk, ip, qw + Oxa 5 mpk, ip, qw
5	5-FU + CF + Irino	5-FU 15 mpk, ip, qd*5 + CF 50 mpk, ip, qw + Irino 50 mpk, ip, q4d*2
6	Nab-pac + Apa	Apa 100 mpk, po, qd*7 + Nab-pac 20 mpk, iv, qd*5
7	TAS102 (Trifluridine)	Trifluridine, 9 mpk, po, bid*7

mpk, mg/kg; po, oral; qd, once a day; 5-FU, 5-fluorouracil; CF, calcium folinate; Oxa, oxaliplatin; ip, intraperitoneal; qw, once a week; Irino, irinotecan; Nab-pac, nab-paclitaxel; Apa, apatinib; q4d, once every four days; iv, intravenous; bid, twice a day.